Citations

Mayo Clinic

Showing 10 of 108599 citations.

Faculty Opinions recommendation of RLIMS-P 2.0: A Generalizable Rule-Based Information Extraction System for Literature Mining of Protein Phosphorylation Information.
Liu, Hongfang

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 9, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725781179.793532863 Get It

Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management
Vašáková, Martina , Walsh, Simon , Leslie, Kevin O., Raghu, Ganesh , Leslie, Kevin, Morell, Ferrán

American Journal of Respiratory and Critical Care Medicine | June 9, 2017 | Volume: 196 | Issue: 6 | Pages: 680-689

10.1164/rccm.201611-2201pp | PMID 28598197 Get It

Hepatic lipophagy: New insights into autophagic catabolism of lipid droplets in the liver
Schulze, Ryan J. , Drizyte‐Miller, Kristina , McNiven, Mark A. , Drižytė, Kristina, Casey, Carol A. , Drizyte-Miller, Kristina

Hepatology Communications | June 9, 2017 | Volume: 1 | Issue: 5 | Pages: 359-369

10.1002/hep4.1056 | PMID 29109982 Get It

The liver is a central fat‐storage organ, making it especially susceptible to steatosis as well as subsequent inflammation and cirrhosis. The mechanisms by which the liver mobilizes stored lipid for energy production, however, remain incompletely defined. The catabolic process of autophagy, a well‐known process of bulk cytoplasmic recycling and cellular self‐regeneration, is a central regulator of lipid metabolism in the liver. In the past decade, numerous studies have examined a selective form of autophagy that specifically targets a unique neutral lipid storage organelle, the lipid droplet, to better understand the function for this process in hepatocellular fatty acid metabolism. In the liver (and other oxidative tissues), this specialized pathway, lipophagy, likely plays as important a role in lipid turnover as conventional lipase‐driven lipolysis. In this review, we highlight several recent studies that have contributed to our understanding about the regulation and effects of hepatic lipophagy. (Hepatology Communications 2017;1:359–369)
Chelation therapy in cardiovascular disease: an update
Sultan, Sulaiman , Murarka, Shishir, Jahangir, Ahad , Mookadam, Farouk , Tajik, A. Jamil , Mookadam, Farouk , Jahangir, Arshad

Expert Review of Clinical Pharmacology | June 9, 2017 | Volume: 10 | Issue: 8 | Pages: 843-854

10.1080/17512433.2017.1339601 | PMID 28597699 Get It

Prevalence and predictors of intracranial aneurysms in patients with bicuspid aortic valve
Egbe, Alexander C. , Padang, Ratnasari , Brown, Robert D. , Khan, Arooj R., Luis, Sushil Allen , Akintoye, Emmanuel , Connolly, Heidi M. , Luis, Sushil A, Huston, John , Luis, Sushil A

Heart | June 8, 2017 | Volume: 103 | Issue: 19 | Pages: 1508-1514

10.1136/heartjnl-2016-311076 | PMID 28596303 Get It

Objective To determine the prevalence and outcomes of intracranial aneurysm (IA) in patients with bicuspid aortic valve (BAV). Methods Retrospective review of patients with BAV who underwent brain MR angiography at the Mayo Clinic from 1994 to 2013. Results There were 678 patients included in this study—mean age 57±13 years, men 480 (71%), mean follow-up 10±3 years (5913 patient-years). Coarctation of aorta (COA) was present in 154 (23%) patients. There were 59 IAs identified in 52 of 678 patients (7.7%). IA was present in 20/154 patients (12.9%) with COA and 32/524 patients (5.7%) without COA (p<0.001). For the patients without COA, female gender and right–left cusp fusion were risks factors for IA in women after adjustment for all potential variables (HR 1.76, CI 1.31 to 2.68, p=0.03). There was no significant trend in the risk for IA across age tertiles: age ≤40 years versus 41–60 years (HR 1.19, p=0.34), and age 41–60 years versus 61–80 years (HR 1.06, p=0.56). Among the 52 patients with IA, enlargement occurred in three patients (6%), rupture in two patients (4%) and four patients (8%) underwent coil embolisation. For the 626 patients without IA at baseline, no patient developed IA over 7±2 years of imaging follow-up. Conclusions BAV is associated with a higher prevalence of IA compared to the general population, and this risk is higher in patients with COA, right–left cusp fusion and female gender.
Analysis of Postoperative Venous Thromboembolism in Patients With Chronic Ulcerative Colitis: Is It the Disease or the Operation?
McKenna, Nicholas P. , Ubl, Daniel S. , Glasgow, Amy E. , Mathis, Kellie L. , Pembérton, John H., Habermann, Elizabeth B. , Glasgow, Amy E. , Behm, Kevin T. , Cima, Robert R. , Habermann, Elizabeth , McKenna, Nicholas P , Glasgow, Amy E

Diseases of the Colon & Rectum | June 8, 2017 | Volume: 60 | Issue: 7 | Pages: 714-722

10.1097/dcr.0000000000000846 | PMID 28594721 Get It

BACKGROUND: Patients with IBD have a higher baseline risk of venous thromboembolism, which further increases with surgery. Therefore, extended venous thromboembolism chemoprophylaxis has been suggested in certain high-risk cohorts. OBJECTIVE: The purpose of this study was to determine whether the underlying diagnosis, operative procedure, or both influence the incidence of postoperative venous thromboembolism. DESIGN: This was a retrospective review. SETTINGS: The American College of Surgeons–National Surgical Quality Improvement Project database was analyzed. PATIENTS: The NSQIP database was queried for patients with chronic ulcerative colitis and non-IBD undergoing colorectal resections using surgical Current Procedural Terminology codes modeled after the 3 stages used for the surgical management of chronic ulcerative colitis from 2005 to 2013. MAIN OUTCOME MEASURES: We measured 30-day postoperative venous thromboembolism risk in patients with chronic ulcerative colitis based on operative stage and risk factors for development of venous thromboembolism. RESULTS: A total of 18,833 patients met inclusion criteria, with an overall rate of venous thromboembolism of 3.8. Among procedure risk groups, venous thromboembolism rates were high risk, 4.4%; intermediate risk, 1.6%; and low risk, 0.7% (across risk groups, p < 0.01). Emergent case subjects exhibited a higher rate of venous thromboembolism than their elective counterparts (6.9% vs 3.1%). Factors significantly associated with venous thromboembolism on adjusted analysis included emergent risk case (adjusted OR = 7.85), high-risk elective case (adjusted OR = 5.07), intermediate-risk elective case (adjusted OR = 2.69), steroid use (adjusted OR = 1.54), and preoperative albumin <3.5 g/dL (adjusted OR = 1.45). LIMITATIONS: Because of its retrospective nature, correlation between procedures and venous thromboembolism risk can be demonstrated, but causation cannot be proven. In addition, data on inpatient and extended venous thromboembolism prophylaxis use are not available. CONCLUSIONS: Emergent status and operative procedure are the 2 highest risk factors for postoperative venous thromboembolism. Extended venous thromboembolism prophylaxis might be appropriate for patients undergoing these high-risk procedures or any emergent colorectal procedures. See Video Abstract at http://links.lww.com/DCR/A339.
β cell self-renewal: Cyclin D2 to the rescue
Javeed, Naureen , Matveyenko, Aleksey V.

Cell Cycle | June 8, 2017 | Volume: 16 | Issue: 14 | Pages: 1326-1327

10.1080/15384101.2017.1337988 | PMID 28594265 Get It

Current Understanding and Management of Splenic Steal Syndrome after Liver Transplant: A Systematic Review
Tsui, Brian , Li, Chaolun , Kapoor, Baljendra , Moon, Eunice , Quintini, Cristiano , Wang, Weiping

Digestive Disease Interventions | June 8, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0037-1603724 Get It

Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience
Wang, Weiping , Shah, Chintan , Sands, Mark, Bullen, Jennifer , Bayona, Pilar, Carey, William, Kapoor, Baljendra , Gupta, Amar C. , Remer, Erick M.

Digestive Disease Interventions | June 8, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0037-1603696 Get It

Lymphaticovenous Bypass: Adaptations and Lessons Learned
Baltzer, Heather L. , Winocour, Sebastian, Harless, Christin A., Saint‐Cyr, Michel, Harless, Christin

Plastic and Reconstructive Surgery - Global Open | June 8, 2017 | Volume: 5 | Issue: 6 | Pages: e1328

10.1097/gox.0000000000001328 | PMID 28740763 Get It

Summary: Advances in microsurgical instruments and techniques have allowed for introduction of lymphaticovenous anastomosis as a potential surgical treatment for patients with upper and lower extremity lymphedema. This article reviews the approach to lymphaticovenous anastomosis patient selection and technical modifications that improve the ease and efficiency of the procedure.